Menu
Sat, 18 January 2025

Newsletter sign-up

Subscribe now
Search

Follow us:

Articles tagged with: medicines
Turning Nuclear Waste into Breakthrough Cancer Treatments Partner content
Health
By Medicines Discovery Catapult
Turning Nuclear Waste into Breakthrough Cancer Treatments
Funding awarded by UKRI to explore sustainable manufacturing of new targeted radiotherapy treatments that could improve patient outcomes
To improve cancer outcomes, we need a medicines framework which is fit for the future Partner content
Health
By Sanofi
To improve cancer outcomes, we need a medicines framework which is fit for the future
Access to innovation is proving increasingly difficult for UK cancer patients. Unpicking the policy barriers is important for achieving the government’s ambitions of improving outcomes. Now is the time for a resolution
New £30m initiative to address global threat by accelerating the pace of antimicrobial innovation Partner content
Health
By Medicines Discovery Catapult
New £30m initiative to address global threat by accelerating the pace of antimicrobial innovation
Pioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could otherwise kill 10 million a year by 2050.
New UK initiative has antimicrobial resistance in its sights Partner content
Health
By Medicines Discovery Catapult
New UK initiative has antimicrobial resistance in its sights
Antimicrobial resistance (AMR) has been identified as one of the top 10 global health threats, posing a risk to public health and the wider economy. Now a new collaboration has been launched that is set to build on the UK’s world-class life sciences base and place the UK at the forefront of global efforts to tackle this urgent health challenge.
Partner content
Health
By Medicines Discovery Catapult
UK Launches Its First National Total-Body PET Platform for Drug Discovery
Patients to benefit from game-changing full-body scans to provide a richer picture of human health for clinical research.
Cutting-edge personalised medicine will transform the way we prevent and treat health conditions
Health
By Baroness Blackwood
Cutting-edge personalised medicine will transform the way we prevent and treat health conditions
Imagine being able to get a timely diagnosis, be prescribed personalised treatments and experience few, if any, side effects.
Sustaining Skills to Supercharge the UK Life Sciences Sector Partner content
Health
By Medicines Discovery Catapult
Sustaining Skills to Supercharge the UK Life Sciences Sector
The UK will only achieve the goal of becoming a science and technology superpower if there is a strong pipeline of talent to fast track growth.
Partner content
Health
By Medicines Discovery Catapult
Industry-First Cancer Screening Technology Boosted by Biomedical Grant Funding
Medicines Discovery Catapult and SMi secure funding to validate cancer biomarker technology.
Partner content
Health
By Medicines Discovery Catapult
Alchemab Therapeutics and Medicines Discovery Catapult Awarded £1.7 Million Grant From Innovate UK to Accelerate Development of Disease-Modifying Therapy for Huntington’s Disease
Company plans to triage a panel of antibodies towards first in human studies.
Strengthening the UK Life Sciences Environment Partner content
Health
By MSD
Strengthening the UK Life Sciences Environment
The UK's life sciences sector has unlocked potential for growth. Chi Onwurah MP, Shadow Minister for Business, Energy and Industrial Strategy, and Dr Natalie White PhD, Executive Clinical Research Director at MSD write about the need for industry-government collaboration and investment in the life sciences sector.
Partner content
Health
By Medicines Discovery Catapult
Medicines Discovery Catapult Appoints International Entrepreneur to Bolster Commercial Expertise
New appointment reflects ambition for growth to drive drug discovery innovation.
LifeArc Joins Forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to Strengthen Antimicrobial Discovery Efforts Partner content
Health
By Medicines Discovery Catapult
LifeArc Joins Forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to Strengthen Antimicrobial Discovery Efforts
Pivotal partnership seeks to transform Cystic Fibrosis research.
World Patient Safety Day- Why the UK must do more to tackle medication errors Partner content
Health
By BD
World Patient Safety Day- Why the UK must do more to tackle medication errors
Every person will at some point in their life, take medications to prevent or treat illness. Medication is a fundamental part of our healthcare system, however, it has the potential to cause serious harm, sometimes even death if incorrectly stored, prescribed, dispensed, administered or if monitored insufficiently.
Partner content
Health
By Medicines Discovery Catapult
Global Expansion: Psychiatry Consortium Welcomes New International Partner
Medicines Discovery Catapult Welcome Shionogi to the Psychiatry Consortium.
Medicines Discovery Catapult and ZEISS Set Sights on Advancing Microscopy Partner content
Health
By Medicines Discovery Catapult
Medicines Discovery Catapult and ZEISS Set Sights on Advancing Microscopy
Medicines Discovery Catapult and ZEISS have announced a new partnership to drive the application of microscopy in drug discovery.
Why Portsmouth needs a medical school Partner content
Health
By University of Portsmouth
Why Portsmouth needs a medical school
A medical school at the University of Portsmouth could help transform the city’s GP provision.
Medicines Discovery Catapult Supports Cystic Fibrosis Week 2022 Partner content
Health
By Medicines Discovery Catapult
Medicines Discovery Catapult Supports Cystic Fibrosis Week 2022
Exploring the theme of ‘lifting the limits together’, this week (13-19 June) marks Cystic Fibrosis (CF) Week 2022. The event is a week-long opportunity to celebrate the courage and resilience shown by the CF community, whilst raising awareness and demystifying misconceptions surrounding the disease.
We must act now to unlock the potential that gene therapies could offer people with rare diseases Partner content
Health
By Pfizer UK
We must act now to unlock the potential that gene therapies could offer people with rare diseases
The formation of a Gene Therapy Taskforce could help ensure people with genetic rare diseases can access the latest scientific advances.
By investing in the right treatment and after-care for stroke survivors, we could improve patient outcomes and save the NHS money
Health
By Sir Robert Neill MP
By investing in the right treatment and after-care for stroke survivors, we could improve patient outcomes and save the NHS money
To begin with, an admission: prior to summer 2019 my knowledge of stroke, like many, was somewhat limited.
Partner content
Health
By Medicines Discovery Catapult
Medicine Discovery Catapult’s Psychiatry Consortium announces new international collaboration to tackle depression
The University of Trento and the University of Bologna are collaborating with global pharmaceutical companies including, Biogen Inc, Janssen Pharmaceutica NV and Merck Sharp and Dohme Corp. in a new Psychiatry Consortium project that will seek to define a new pharmacological approach to treat depression.
We must learn from Covid to avert an antibiotic resistance pandemic
Health
By Kevin Hollinrake MP
We must learn from Covid to avert an antibiotic resistance pandemic
Unlike Coronavirus, we have a chance to solve antibiotic resistance before it spirals out of control.
Partner content
Environment
By NOAH
Animal health industry associations warn solutions are needed to address Northern Ireland Protocol veterinary medicines supply concerns
NOAH, along with AnimalhealthEurope, is concerned that the Northern Ireland Protocol (NIP) introduced following the UK’s exit from the EU could, in its current format, cause substantial disruption to veterinary medicines supply. In exchanges with the authorities, the associations have put forward solutions to avoid these supply issues, and the consequent negative impact on animal health and welfare they would cause.
How can we implement effective strategies to alleviate and support long-COVID? Partner content
Health
By British Association for Nutrition and Lifestyle Medicine (BANT)
How can we implement effective strategies to alleviate and support long-COVID?
With the so-called curse of “Long-COVID” estimated to affect a third of people post-infection, the legacy of this virus is set to disrupt populations for years to come. It is still unclear as to why some people experience the virus more, or less, severely, and why prolonged symptoms linger in some but not in others.
We must unlock the full potential of cell and gene therapies
Health
By Daniel Zeichner MP
We must unlock the full potential of cell and gene therapies
In July, I was delighted to chair a Policy Connect roundtable on cell and gene therapies, to consider how they can contribute to better patient care, the wider health service and the economy.